Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kiora Pharmaceuticals (KPRX)
NASDAQ:KPRX
RESEARCH TOOLSreports
Holding KPRX?
Track your performance easily
KPRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.00 - $8.98
Previous Close$3.52
Volume11.94K
Average Volume (3M)28.62K
Market Cap
$10.92M
Enterprise Value-$16.78M
Total Cash (Recent Filing)$27.78M
Total Debt (Recent Filing)$82.32K
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Nov 11, 2024EPS Estimate
-$0.76Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.70
Shares Outstanding2,970,545
10 Day Avg. Volume74,606
30 Day Avg. Volume28,620
Standard Deviation0.27
R-Squared0.00328
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.32
Price to Sales (P/S)0.65
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.05
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda-1.97
Forecast
1Y Price Target
$30.33Price Target Upside761.65% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Kiora Pharmaceuticals News
PremiumCompany Announcements
Kiora Pharmaceuticals Gains Approval for Phase 2 Trial
PremiumCompany Announcements
Kiora Pharmaceuticals Announces Board Appointment, Regains Nasdaq Compliance
PremiumCompany Announcements
Kiora Pharmaceuticals Unveils Updated Investor Presentation
Ownership Overview
2.63% Insiders
0.60% Mutual Funds
24.61% Other Institutional Investors
72.07% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
KPRX FAQ
What was Kiora Pharmaceuticals’s price range in the past 12 months?
Kiora Pharmaceuticals lowest stock price was $3.00 and its highest was $8.98 in the past 12 months.
What is Kiora Pharmaceuticals’s market cap?
Currently, no data Available
When is Kiora Pharmaceuticals’s upcoming earnings report date?
Kiora Pharmaceuticals’s upcoming earnings report date is Nov 11, 2024 which is in 4 days.
How were Kiora Pharmaceuticals’s earnings last quarter?
Kiora Pharmaceuticals released its earnings results on Aug 09, 2024. The company reported -$0.53 earnings per share for the quarter, beating the consensus estimate of -$0.857 by $0.327.
Is Kiora Pharmaceuticals overvalued?
According to Wall Street analysts Kiora Pharmaceuticals’s price is currently Undervalued.
Does Kiora Pharmaceuticals pay dividends?
Kiora Pharmaceuticals does not currently pay dividends.
What is Kiora Pharmaceuticals’s EPS estimate?
Kiora Pharmaceuticals’s EPS estimate is -$0.76.
How many shares outstanding does Kiora Pharmaceuticals have?
Kiora Pharmaceuticals has 2,970,545 shares outstanding.
What happened to Kiora Pharmaceuticals’s price movement after its last earnings report?
Kiora Pharmaceuticals reported an EPS of -$0.53 in its last earnings report, beating expectations of -$0.857. Following the earnings report the stock price went up 2.761%.
Which hedge fund is a major shareholder of Kiora Pharmaceuticals?
Currently, no hedge funds are holding shares in KPRX
---
Kiora Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$30.33 (761.65% Upside)
$30.33 (761.65% Upside)
Insider Transactions
Bought Shares
Worth $46.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.7%
Last 30 Days ▲ 5.7%
Last 30 Days ▲ 5.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.91%
12-Months-Change
Fundamentals
Return on Equity
13.69%
Trailing 12-Months
Asset Growth
105.25%
Trailing 12-Months
Company Description
Kiora Pharmaceuticals
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.
---
KPRX Stock 12 Month Forecast
Average Price Target
$30.33
▲(761.65% Upside)
Technical Analysis
Best Analysts Covering KPRX
1 Year
1 Year Success Rate
1/13 ratings generated profit
1 Year Average Return
-45.42%
reiterated a buy rating 10 days ago
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 7.69% of your transactions generating a profit, with an average return of -45.42% per trade.
---